By Dana Jacoby

Leveraging the Lucrative Opportunities in Women’s Health Sector

In an era where strategic investment could be the difference between moderate and monumental returns, focusing on growing sectors has become paramount. Among the sectors breaking the mold, women’s health companies are stepping into the limelight, asserting themselves as lucrative investment opportunities.

This article covers five compelling reasons why there is significant ROI potential when investing in this sector.

1. Unmatched Buying Power in the Women’s Health Market

Women have a dominant presence in the global health market, wielding unparalleled buying power. They are responsible for making approximately 80% of healthcare decisions, thereby driving the majority of the demand in the market.

Investing in women’s health companies offers opportunities to access this spending power, potentially promising lucrative returns.

2. A Growing Focus on Femtech

The femtech sector, particularly concerning sexual health, menstruation and menopause, contraception, and fertility, represents a rapidly growing industry. By 2027, the global femtech market is expected to escalate to a whopping $60 billion.

Investments in this sector not only address critical needs, but also venture into a growing market that predominantly affects women, who we know hold the majority spending power in healthcare, thereby offering potentially high returns.

3. Addressing the Historical Underinvestment in Women’s Health

The world of women’s health startups is witnessing a surge as entrepreneurs and investors are beginning to realize the considerable gap left by historical underinvestments. This burgeoning sphere offers a golden opportunity to invest in startups that could potentially evolve into unicorns, thereby promising high yields.

Early entry into this market not only supports filling a critical gap but also stands as a lucrative investment avenue.

4. The Rise of Independent, High-Earning Women

Women are progressively becoming higher earners, with 60% of university graduates now being women, and more women embracing financial independence. A recent survey highlights that the share of women out-earning their partners has seen a significant rise.

This shift translates to an increased healthcare expenditure, which makes investments in women’s health companies both strategically intelligent and potentially high-yielding.

5. Aligning with ESG Growth: Social Impact and Community Benefits

Investing in women’s health offers more than just substantial financial returns; it aligns well with the increasing emphasis on Environmental, Social, and Governance (ESG) criteria that are significantly swaying investment decisions.

The social component of ESG is prominently satisfied as investments in women’s health companies often encourage community upliftment and improve the overall health landscape. This alignment not only promises high returns but also caters to the growing demand from consumers and investors seeking responsible investment avenues that champion social causes.

Challenges Ahead

Despite the strong prospects, it is important to note that investments in the realm of women’s health face hurdles such as gender biases in medical research and the historical underfunding of this sector.

Final Thoughts

Investing in women’s health companies represents a future-forward approach in the healthcare sector. As the industry evolves, recognizing and capitalizing on the growth potential of women’s health can lead to not only remarkable financial gains but also foster a healthier and more equitable society for all.

To learn about what we do, or get further insights on healthcare hot topics, visit the Vector Medical Group Insights.


  1. Women in healthcare make 80% of purchasing decisions
  2. The value of investing in women’s health
  3. Women now make up almost 60% of college students—an all-time high
  4. More women out-earn their husbands
  5. Women and Sustainability: Investing in Women’s Health
  6. Why women’s health is a 500M problem worth solving